Recent studies have shown that decreased FOXO1 protein was closely linked to onset and progression of many types of human cancer, which indicated that FOXO1 may exert anti-tumor activity and may be a promising therapeutic target 11-14. This evidence concerns the gene FOXO1 and cancer.